AzTrials
AzTrials

Obsessive-Compulsive DisorderNCT04688554

Psychosocial, Behavioral, and Radiologic Changes Following Radiosurgery for Benign Neurologic Disease

An observational study of Obsessive-Compulsive Disorder and Pain, Intractable, run by Vanderbilt University Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A number of studies from the literature suggest important behavioral, psychosocial, or radiologic changes occur following significant neurologic events or interventions such as stroke, neurosurgery, medications, radiation, systemic therapy, or injury. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
fMRI and DTI, Behavioral questionnaires and Disease-Specific Patient-Reported Outcomes
How many people
18 participants
Where
1 siteUnited States
Study dates
25 Aug 2020to 1 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: VUMC adult patients with neurologic disease or patients with neurologic interventions such as neurosurgical procedures or radiation therapy. Men and women of any ethnicity, race or socioeconomic status who meet inclusion criteria will be offered enrollment into the study. Patient will be greater than 18 years of age and meet inclusion and exclusion criteria. Patients eligible for this study will include patients with neurologic events, including but not limited to stroke, depression, infections, psychiatric disease. Intervention is not part of this study, however, patients receiving neurologic interventions, such as neurosurgical procedures or radiation therapy, would be eligible.

Who may be able to join

  • Age ≥ 18 years old and willing and able to sign a written informed consent.
  • Eligible for Brain MRI
  • History of neurologic event or intervention OR future planned neurologic intervention

Who cannot join

  • Contraindications to MRI of the brain
  • Patient declining participation in study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232-5671

Other trials in United States

About this study

Official title: Psychosocial, Behavioral, and Radiologic Changes Following Neurologic Events or Interventions: A Prospective, Non-Interventional, Observational Study

A number of studies from the literature suggest important behavioral, psychosocial, or radiologic changes occur following significant neurologic events or interventions such as stroke, neurosurgery, medications, radiation, systemic therapy, or injury. The purpose of this study is to describe these changes with advanced neurologic imaging and targeted neurologic and neuropsychiatric assessments. This is a non-interventional observational study of minimal risk to participants as there is no medical intervention. The results of this study will be used to inform patients, scientists, and society in the development of future treatments.

Read the detailed description

Functional magnetic resonance imaging (fMRI) and diffusion tensor tractography (DTI) have rapidly expanded since its emergence two decades ago. fMRI is well established as the single most powerful method for detecting changes in neural activity in vivo, albeit indirectly by detection of changes in blood oxygenation level dependent (BOLD) signals that reflect hemodynamic changes subsequent to neural activity. A conventional fMRI experiment involves the comparison of two or more brain states followed by statistical tests to identify which brain regions were involved in a particular task. The identification of patterns of highly correlated low-frequency MRI signals in the resting brain provides a powerful approach to delineate and describe neural circuits, and an unprecedented ability to assess the manner in which distributed regions work together to achieve specific functions. Since the first reports of temporal correlations in BOLD baseline signals, several distinct cortical long-range networks have been identified and characterized in the resting state, including a default mode network. Moreover, observations of altered resting state connectivity in several disorders and as a function of behavior or cognitive skills suggest these correlations reflect an important level of brain organization and may play a fundamental role in the execution and maintenance of various brain functions. DTI is also an exceedingly important imaging modality that has elucidated the neural connectivity inherent between various cortical and subcortical structures. DTI is routinely used and has enhanced our understanding of functional connections between various parts of the brain. Prior to interventions, DTI is commonly obtained, so that interventionists can avoid critical circuitry. There is suggestion that both fMRI and DTI imaging is influenced by organic or interventional variables, however this is understudied. The neuroscientists and clinicians would greatly value information that would expand our working knowledge of the basic neural substrates and functional neural changes that occur in patients organically or after interventions. A non-invasive, non-interventional, observational study is needed to show the changes that happen to patients organically or in standard of care settings. A greater working understanding of the neural connectivity and changes that happen in the brain is of great future benefit to patients, science, and society as well as future therapeutic development such as post-stroke care, rehabilitation, post-traumatic brain injury, or post-treatment care in the brain that has previously been influenced by intervention or disease.

Being tested
fMRI and DTI, Behavioral questionnaires, Disease-Specific Patient-Reported Outcomes, Behavioral tests
Keywords
Stereotactic Radiosurgery, Cingulotomy, Capsulotomy
Medical subject headings
Obsessive-Compulsive Disorder, Pain, Intractable, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • fMRI and DTIDiagnostic test

    Neurologic imaging correlates

  • Behavioral questionnairesBehavioural

    RAND 36-item Quality of Life survey, Mini Mental Status Exam, MOCA Cognitive Exam

  • Disease-Specific Patient-Reported OutcomesBehavioural

    Y-BOCS Survey, QUEST, PDQ39, PHQ2 Depression Screening, PHQ9 Depression Inventory, Beck's Depression Inventory, PROMIS Pain Intensity Short Form 3, McGill Pain Scale, Visual Analog pain scale, FTM (Tremor Scale)

  • Behavioral testsBehavioural

    Behavioral tests may include one or more of the following procedures: Upper extremity testing, Perdue Peg Board testing, Hand tactile detection and discrimination test, Temperature and pain threshold testing, Lower extremity Testing, Myomotion Inertial Motion Testing.

Study groups in NCT04688554
Study groupRoleWhat they receive
Refractory Obsessive Compulsive DisorderfMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical capsulotomy
Receives: Diagnostic Test: fMRI and DTI; Behavioral: Behavioral questionnaires; Behavioral: Disease-Specific Patient-Reported Outcomes; Behavioral: Behavioral tests
Refractory PainfMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical cingulotomy
Receives: Diagnostic Test: fMRI and DTI; Behavioral: Behavioral questionnaires; Behavioral: Disease-Specific Patient-Reported Outcomes; Behavioral: Behavioral tests
Refractory TremorfMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical thalamotomy
Receives: Diagnostic Test: fMRI and DTI; Behavioral: Behavioral questionnaires; Behavioral: Disease-Specific Patient-Reported Outcomes; Behavioral: Behavioral tests
Refractory DepressionfMRI, DTI, behavioral, psychological, and disease-specific changes following radiosugical cingulotomy
Receives: Diagnostic Test: fMRI and DTI; Behavioral: Behavioral questionnaires; Behavioral: Disease-Specific Patient-Reported Outcomes; Behavioral: Behavioral tests

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Describe changes in Obsessive Compulsive Disorder disease burden after stereotactic radiosurgery.

    Yale-Brown Obsessive Compulsive Scale questionnaire

    Measured: Every 3 months for 1 year or through study completion

  2. Describe changes in Depression disease burden after stereotactic radiosurgery.

    Beck's Depression inventory

    Measured: Every 3 months for 1 year or through study completion

  3. Describe changes in Pain disease burden after stereotactic radiosurgery.

    McGill Pain Scale

    Measured: Every 3 months for 1 year or through study completion

Secondary outcomes (2)
  1. Describe changes in cognition after stereotactic radiosurgery.

    Montreal Cognitive Assessment

    Measured: Every 3 months for 1 year or through study completion

  2. Describe changes in radiologic parameters after stereotactic radiosurgery.

    Brain MRI

    Measured: Every 6 months for 1 year or through study completion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2020
  2. Study start25 Aug 2020
  3. Primary completion1 Feb 2024
  4. Study completion1 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04688554
Sponsor's protocol ID
200209
Status last verified
Dec 2024
First submitted
16 Sep 2020
Last updated
6 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Research data will be shared upon reasonable request to the principal investigator.

Questions about this trial

What is this clinical trial studying?

An observational study of Obsessive-Compulsive Disorder and Pain, Intractable, run by Vanderbilt University Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Describe changes in Obsessive Compulsive Disorder disease burden after stereotactic radiosurgery. (time frame: Every 3 months for 1 year or through study completion). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in